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A b s t r a c t
Background: Myocardial infarction (MI) care and treatment contribute greatly to the patients’ fatality and mortality. Assessing 
and monitoring mortalities and the effective factors are necessary in MI care and treatment programs. No comprehensive 
and population-based study has yet been conducted in Iran to determine the epidemiological pattern of MI, and particularly 
in-hospital mortality rate and the effective factors.
Aim: To determine the epidemiological pattern of MI based on person-, time-, place-, and mortality-associated risk factors.
Methods: This was a prospective, population-based cohort study, which analysed the data of 20,750 MI patients in Iran in 
2012. MI was diagnosed based on ICD-10: codes I21 and I22. The cohort of the patients was defined in terms of the date at 
diagnosis, hospitalisation, and the date at discharge (recovery or death due to MI). The in-hospital mortality rate was calculated 
by Cox regression. Univariate analysis and multiple logistic regression were used to determine the effective factors on the 
patients’ mortality. The odds ratio (95% confidence interval [CI]) was reported using Stata software. 
Results: The relative frequency of in-hospital mortality was 12.1%. The in-hospital mortality rate was higher in women than 
in men, and 6.74 (95% CI 6.4–7.0) per 100 person-years were at risk of death. The highest relative mortality (13.2%) was ob-
tained in January (11 Dey to 11 Bahman in the Persian calendar) and the lowest (5.9%) in May (11 Ordibehest to 10 Khordad 
in the Persian calendar). Age of over 84 years, female gender, educational level, smoking, lack of thrombolytic therapy, type 
2 diabetes, chest pain prior to arriving in hospital, right bundle branch block, ventricular tachycardia, percutaneous coronary 
intervention, lateral MIs, and ST segment elevation myocardial infarction (STEMI) were determinants of in-hospital mortality 
in the patients. The relative frequency of mortality was higher from STEMI (83.7% of deaths in registry) vs. non-STEMI (16.3% 
of deaths in registry).  
Conclusions: STEMI, lack of thrombolytic therapy, age of over 84 years, and ventricular tachycardia have the greatest ef-
fect on in-hospital mortality in MI patients. The results of this study are helpful in planning for monitoring and promotion of 
healthcare of the patients.
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INTRODUCTION
Cardiovascular disease (CVD) is considered as one of the 
important priorities in the health systems of all countries, in-
cluding Iran. The burden of these diseases is increasing in low-, 
moderate-, and high-income countries [1, 2]. Worldwide, 
Finland and Japan have the highest and lowest myocardial 
infarction (MI) incidence rate, respectively [3–5]. More than 
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1/3 of the mortalities in Iran are due to CVD, so it is a serious 
challenge facing the country’s healthcare system [6–9]. 
Few studies have investigated the factors relevant to 
in-hospital mortality [10]. The decrease in mortalities due to 
MI is mainly related to the decreased fatality of the disease, 
the enhanced healthcare of the disease, and appropriate treat-
ment. The healthcare and treatment of MI have a pivotal role 
in patient fatality and mortality. The epidemiological pattern of 
MI varies between different communities [2, 10]. Reports on 
population-based MI incidence rates are rare in developing 
countries. So far, no comprehensive and population-based 
work has been conducted in Iran to determine the epide-
miological pattern of MI, particularly the effective factors on 
patient mortality [11]. Most MIs and the mortalities due to 
them seem to be preventable. The first step is to determine 
and explain their epidemiology in order to plan for and 
improve the process of healthcare and treatment. This study 
was conducted to determine the epidemiological pattern of 
MI based on person-, time-, place-, and mortality-associated 
risk factors in the patients in Iran in 2012.
MeThODs
In this prospective, population-based cohort study the data 
of 20,750 MI patients in 540 hospitals in Iran in 2012 were 
analysed. The cohort of the study consisted of patients reg-
istered in the Iranian Myocardial Infarction Registry of the 
Iran Health and Medical Education Ministry (Department of 
Cardiovascular Disease Prevention) in hospitals with a car-
diology ward across 31 provinces of Iran using the date at 
arrival to and discharge from the hospital. Data collection is 
mandatory in all hospitals although some private and military 
hospitals do not participate. The coverage of the MI registry 
was 87% [11, 12]. Inclusion criteria were defined based on 
International Classification of Diseases (ICD; codes I21, I22). 
Patients with no definite diagnosis of MI by the cardiologist 
were excluded from the study. MIs are generally classified 
into ST segment elevation myocardial infarction (STEMI) 
and non-STEMI (NSTEMI). Echocardiography (ECG) is used 
to differentiate between the two types of MIs based on the 
shape of the tracing. An ST section of the trace higher than 
the baseline is called STEMI, which usually requires more 
invasive treatment. For a person to qualify as having STEMI 
the ECG must show new ST elevation in two or more adjacent 
ECG leads [13].
The demographic data of the patients, including age, 
gender, educational level, place of residence, and individual, 
clinical, and laboratory risk factors — such as the date at MI 
incidence, duration of hospitalisation, type 2 diabetes, hyper-
tension, smoking, hyperlipidaemia, type of diagnosis, treat-
ment, place of MI, and pain pattern, were considered as the 
independent variables (predictor), and in-hospital mortality 
as a dependent variable. The above variables were measured 
based on national protocol and World Health Organisation 
(WHO) standards and recorded by the cardiologist and matron 
of the cardiology ward in electronic medical files.
Educational level was classified as zero (illiteracy), 1–5 years 
(primary), 6–9 years (guidance), 10–12 years (high school), and 
more than 12 years (university). The cohort of the patients was 
defined in terms of the date at diagnosis, hospitalisation, and 
the date at discharge (recovery or death due to MI).
Multiple logistic regression was used for modelling and 
simultaneous examination of the variables’ effect as well as 
controlling confounding variables. Variables with a significance 
value of less than 0.2 were entered into the multivariate 
model. The presuppositions were checked and confirmed. 
Goodness-of-fit was assessed by Hosmer-Lemeshow test and 
obtained as acceptable (p = 0.415). For the final model the 
area under receiver operating characteristic (ROC) curve was 
obtained 0.844 (Fig. 1). The in-hospital mortality rate was 
calculated by Cox regression. The crude incidence rate was 
calculated per 100,000 individuals in different age groups. For 
calculation of actual incidence rates in the denominator, the 
data from a population census by the Statistical Centre of Iran 
in 2011 were used. Quantitative variables were reported by 
mean ± standard deviation (SD) and the grouped variables 
by frequency and percentage. The rates, odds ratio (OR), 
and 95% confidence interval (CI) were calculated using Stata 
software (Stata Corp. 2011. Stata Statistical Software: Release 
12. College Station, TX: Stata Corp LP). P < 0.05 was con-
sidered as significant. 
ResUlTs
In total 15,033 (72.4%) patients were male. The mean ± SD 
age of the patients was 61.2 ± 13.4 years. The mean age at MI 
incidence was significantly lower in men (59.6 ± 13.3 years) 
than in women — 65 ± 12.6 years (p = 0.001). The mean age 
at MI incidence was significantly different by the province of 
residence (p = 0.001). The demographic characteristics and 
the risk factors under investigation are shown in Table 1. Ex-
cept for coronary artery bypass grafting (CABG), right bundle 
branch block (RBBB), and ventricular fibrillation, all of the 
studied variables were significantly different between men 
Figure 1. The area under receiver operating characteristic 
(ROC) curve for final logistic model
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frequency of mortality from STEMI and NSTEMI was 83.7% 
and 16.25%, respectively (2,103 vs. 408). 
Based on Cox regression model, the in-hospital mortality 
rate was 6.74 (95% CI 6.4–7) per 100 person-years. This rate 
was 6.12 (95% CI 5.83–6.43) and 8.36 (95% CI 7.81–9.94) 
in men and women, respectively. The men/women ratio of 
mortality rate was 1.36 (95% CI 1.2–1.4).
In the final model of determinants of MI-associated 
in-hospital mortality, age over 84 years, female gender, 
educational level, smoking, lack of thrombolytic therapy, 
type  2 diabetes, chest pain prior to arriving in hospital, 
RBBB, ventricular tachycardia (VT), percutaneous coronary 
intervention (PCI), lateral MIs, and STEMI were present. The 
OR (95% CI) of the studied risk factors is shown in Table 2 as 
crude and standardised.
DIsCUssION
In this study, the epidemiologic status of MI incidence, its asso-
ciated mortality, and related factors were reported for the first 
Table 1. Demographic characteristics and clinical and lifestyle risk factors in the study population
Characteristics Total Men Women P
Age groups [year]: 0.001
< 30 129 (0.62%) 113 (0.75%) 16 (0.28%)
30–64 12375 (59.6%) 9701 (64.5%) 2674 (46.7%)
65–84 7477 (36%) 4743 (31.5%) 2734 (47.8%)
≥ 85 769 (3.7%) 476 (3.2%) 293 (5.2%)
Gender 20750 (100%) 15033 (72.45%) 5717 (27.55%) 0.001
Education: 0.001
Illiterate 9611 (46.3%) 5488 (36.5%) 4123 (72.12%)
Primary 4941 (23.8%) 3906 (25.9%) 1035 (18.1%)
Guidance 1940 (9.3%) 1684 (11.2%) 256 (4.48%)
High-school 2992 (14.4%) 2742 (18.2%) 250 (4.37%)
University 1266 (6.1%) 1213 (8.1%) 53 (0.93%)
Smoking 5443 (26.2%) 4291 (28.5%) 1152 (20.1%) 0.001
Hypertension 7376 (35.5%) 4303 (28.6%) 3073 (53.7%) 0.001
Type 2 diabetes 4612 (22.2%) 2701 (18%) 1911 (33.4%) 0.001
Dyslipidaemia 3710 (17.8%) 2265 (15%) 1445 (25.3%) 0.001
CABG 539 (2.6%) 383 (2.5%) 156 (2.7%) 0.464
PCI 1431 (7%) 1101 (7.3%) 330 (5.8%) 0.001
Chest pain 2229 (10.7%) 1551 (10.3%) 678 (11.9%) 0.001
Lack thrombolytic 9222 (44.5%) 6966 (46.3%) 2256 (39.4%) 0.001
RBBB 383 (1.8%) 229 (1.5%) 154 (2.7%) 0.001
VF 511 (2.5%) 389 (2.6%) 122 (2.2%) 0.537
VT 1198 (5.7%) 916 (6%) 282 (4.9%) 0.001
STEMI 15729 (75.8%) 11681 (77.7%) 4048 (70.81%) 0.001
NSTEMI 5021 (24.2%) 3352 (22.3%) 1669 (29.19%) 0.001
CABG — coronary artery bypass grafting; NSTEMI — non ST-segment elevation myocardial infarction; PCI — percutaneous coronary intervention; 
RBBB — right bundle branch block; STEMI — ST-segment elevation myocardial infarction; VF — ventricular fibrillation; VT — ventricular tachycardia
and women. In final regression model, except for CABG all 
variables were significant (Table 2). In univariate analysis, 
hypertension history and body mass index were yielded as 
significant risk factors. However, they were not significant in 
multivariate analysis. The highest relative frequency (13.2%) 
was obtained in January (11 Dey to 11 Bahman in the Persian 
calendar) and the lowest (5.89%) in May (11 Ordibehest to 
10 Khordad in the Persian calendar). Details of the relative 
frequencies of MI incidence for each month and the Iranian 
calendar are shown in Table 3. In univariate analysis the death 
OR in July (10 Tir to 10 Mordad in the Persian calendar) was 
1.33 times (95% CI 1.05–1.6) higher than that in March (the 
first month in the Persian calendar), with a significant differ-
ence. The lowest death OR (0.82) was obtained for October 
(95% CI 0.7–0.99), which was significant. In multivariate 
analysis, the OR in the year’s months was not significant. 
The relative frequency of disease incidence for each month is 
shown in Figure 2 for men and women. The relative frequency 
of in-hospital mortality was 12.1% (2,511 cases). The relative 
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Table 2. Unadjusted and adjusted odds ratio for the effect of characteristics on mortality
Characteristics Unadjusted OR Adjusted OR 95% CI
OR SE P OR SE P
Age groups [year]:
< 30 Ref. – – – – – –
30–64 1.13 0.3 0.683 0.91 0.31 0.804 0.46–1.81
65–84 1.68 0.5 0.099 1.44 0.5 0.293 0.72–2.87
≥ 85 6.75 2.1 0.001 7.84 2.8 0.001 3.85–15.9
Women 1.42 0.06 0.001 1.23 0.06 0.001 1.11–1.37
Education:
Illiterate 1.36 0.12 0.001 0.93 0.1 0.555 0.76–1.15
Primary 0.97 0.09 0.77 0.81 0.08 0.068 0.65–1.01
Guidance 0.68 0.08 0.002 0.64 0.08 0.001 0.5–0.83
High-school 0.75 0.08 0.01 0.69 0.08 0.002 0.55–0.87
University Ref. – – – – – –
Smoking 1.3 0.06 0.001 1.24 0.06 0.001 1.12–1.38
Type 2 diabetes 1.14 0.05 0.008 1.18 0.06 0.002 1.06–1.32
Chest pain 6.63 0.3 0.001 3.95 0.24 0.001 3.49–4.46
Lack of TT 2.07 0.08 0.001 3.06 0.16 0.001 2.75–3.42
RBBB 2.54 0.2 0.001 2.05 0.33 0.001 1.48–2.83
VT 2.17 0.15 0.001 2.23 0.2 0.001 1.86–2.65
STEMI 3.76 0.16 0.001 3.85 0.21 0.001 3.45–4.3
PCI 0.39 0.04 0.001 0.69 0.08 0.005 0.54–0.89
CABG 1.08 0.14 0.523 1.15 0.16 0.304 0.87–1.53
Lateral MI 1.57 0.13 0.001 1.93 0.19 0.001 1.58–2.34
CABG — coronary artery bypass; CI — confidence interval; OR — odds ratio; MI — myocardial infarction; SE — standard error; PCI — percutaneous 
coronary intervention; RBBB — right bundle branch block; STEMI — ST-segment elevation myocardial infarction; VT — ventricular tachycardia;  
TT — thrombolytic therapy
Table 3. Details of relative frequency of myocardial infarction 
incidence per month
Period (in Persian/Gregorian calendar) Frequency (%)
11 Day to 11 Bahman/January 2739 (13.2%)
12 Bahman to 9 Esfand/February 2045 (9.85%)
10 Esfand to 10 Farvardin/March 1547 (7.45%)
11 Farvardin to 10 Ordibehest/April 1450 (6.98%)
11 Ordibehest to 10 Khordad/May 1224 (5.89%)
11 Khordad to 9 Tir/June 1463 (7.05%)
10 Tir to 10 Mordad/July 1497 (7.21%)
11 Mordad to 9 Shahrivar/August 1334 (6.42%)
10 Shahrivar to 8 Mehr/September 1613 (7.77%)
9 Mehr to 10 Aban/October 1798 (8.66%)
11 Aban to 9 Azar/November 1960 (9.44%)
10 Azar to 10 Day/December 2080 (10.02%)
chest pain prior to arriving in hospital, RBBB, VT, PCI, lateral 
MIs, and STEMI increased the mortality rate due to MI in Iran. 
The results of our study offer an appropriate opportunity for 
managing, evidence-based decision making, and planning for 
the prevention and control of MI and its related mortalities 
in Iran. Although CVDs have been decreasing in developed 
and high-income countries, this trend, by several reports, is on 
rise in developing and moderate- and low-income countries, 
such as Iran [3, 13–15].
According to the Iranian Mortality Registry, the mortality 
rate due to CVD and MI was reported, respectively, as 171 and 
85 per 100,000. In our study, the MI mortality incidence rate 
was obtained at 6.74 (per 100 person year). The mortality rate 
in Iran is lower compared to that in the world and the Eastern 
Mediterranean region [11].
The main reason for this difference seems to be the 
ways of accessing and receiving healthcare, several and vari-
ous risk factors worldwide, and Iran’s young population. To 
compare the determinants of in-hospital mortality risk with 
those investigated in other studies, no similar study in Iran’s 
neighbouring countries was found as far as we searched. In 
time in Iran. Age over 84 years, female gender, educational 
level, smoking, lack of thrombolytic therapy, type 2 diabetes, 
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our study, a difference in the age at MI incidence was noted 
between men and women, which is consistent with other 
studies. Age over 84 years was yielded as a risk factor for 
death, in agreement with works in other countries such as 
Japan and Korea [4, 16–18].
The incidence rate in our study was higher compared to 
Japan and Korea and lower compared to Finland and Australia. 
The in-hospital mortality rate was higher in women compared 
to men in Japan. Also, the in-hospital mortality rate was lower 
in the patients in Iran compared to Japan [3, 4]. In Korea, 
19.2% of MI patients had diabetes, 67.3% were smokers, and 
61.2% had STEMI. In our study, the prevalence of diabetes 
was 22.2%, which is higher compared to Japan. In our study, 
hypertension association with in-hospital mortality was signifi-
cant (p = 0.011, OR = 1.11) in univariate analysis, but it was 
not significant in multivariate analysis. In Japan, hypertension 
was significantly associated with the patients’ mortality [18].
In a study, age, female gender, lack of thrombolytic 
therapy, and STEMI were the most important determinants of 
survival and mortality in the MI patients, which is similar to 
our study. Hypertension, type 2 diabetes, and smoking were 
obtained as, respectively, 49%, 53%, and 30% in multiple 
regression and were not significant as risk factors for death 
[19]. In a similar study, 73% of the patients were male and 
their mean age was 61.8 years, which is similar to our study. 
History of CABG, PCI, and diabetes were reported respec-
tively 4.4%, 12.5%, and 25.3% in the patients; these rates 
were obtained, respectively, as 2.6%, 3.2%, and 22.2% in our 
study, which are lower compared to that study [20]. In our 
study, in-hospital mortality rate due to MI was 12%, which is 
lower compared to 23.3% reported by another study [21]. In 
a study in India, the mean age of the patients was reported as 
57.5 years, which is lower compared to Iran. In India, 30.4% 
of the patients had type 2 diabetes, 37.7% had hypertension, 
and 40% were smokers; the corresponding figures in our study 
are, respectively, 22.2%, 35.5%, and 26.2%. In India, despite 
the high prevalence of risk factors, the death percentage was 
6.7%, which is lower compared to our study. In our study, 83% 
of the patients were hospitalised for less than six days. In India, 
this figure was 57.3%. The difference in mortality percentage 
between our study and the study in India could be due to the 
different pattern of, and access to, treatment as well as different 
approaches to providing healthcare services [22]. In-hospital 
mortality due to MI in the United States (10–70%) was higher 
in blacks compared to whites and higher in individuals over 
70 years of age compared to other age groups [23]. The dif-
ference in incidence rate, mortality, the factors relevant to 
in-hospital mortality, and the mean age could be due to the 
old populations in some countries, e.g. the United States and 
Japan, the difference in life expectancy and lifestyle, the dif-
ference in distribution of and coping with CVD risk factors, as 
well as approaches to providing healthcare [24, 25]. Failure to 
follow up the patients for 28 days, failure to include MI death 
cases outside hospital and in the home, and failure to calculate 
the patients’ survival time were some of the limitations of the 
present study, which are recommended to be eliminated in 
future studies. Being population-based, recruiting a large sam-
ple size, measuring the variables by the same method and per 
WHO standards, and being the first report on MI incidence in 
Iran could be considered as strengths of our work.
Figure 2. Frequency of myocardial infarction per month in 2012
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CONClUsIONs
In view of the results obtained in the present study, STEMI and 
age over 84 years are likely to contribute most to in-hospital 
mortality in patients with MI. The findings of the present 
study could be helpful for planning in health systems as well 
as monitoring and improving the patients’ care and treatment.
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S t r e s z c z e n i e
Wstęp: Opieka zdrowotna i sposób leczenia mają ogromny wpływ na śmiertelność i umieralność chorych z zawałem serca 
(MI). Programy opieki zdrowotnej i leczenia MI muszą uwzględniać ocenę i monitorowanie śmiertelności oraz determinu-
jących ją czynników. W Iranie nie przeprowadzono dotychczas kompleksowego badania populacyjnego w celu określenia 
epidemiologii MI, a w szczególności śmiertelności wewnątrzszpitalnej i wpływających na nią czynników.
Cel: Badanie przeprowadzono w celu określenia epidemiologii MI na podstawie danych dotyczących pacjentów, czasu, 
miejsca i czynników ryzyka związanych ze śmiertelnością.
Metody: Było to prospektywne populacyjne badanie kohortowe, w którym analizowano dane 20 750 chorych, którzy przebyli 
MI w Iranie w 2012 r. Zawał serca diagnozowano zgodnie z klasyfikacją ICD-10, kody I21 i I22. Określono grupę pacjentów 
pod względem daty ustalenia rozpoznania, hospitalizacji i daty wypisania ze szpitala (powrót do zdrowia lub zgon z powodu 
MI). Wskaźnik śmiertelności wewnątrzszpitalnej obliczono metodą regresji Coxa. W celu określenia czynników wpływających 
na śmiertelność wewnątrzszpitalną zastosowano analizę jednozmiennową i analizę wielokrotnej regresji logistycznej. Iloraz 
szans [95-procentowy przedział ufności (CI)] określono, stosując oprogramowanie Stata.
Wyniki: Śmiertelność wewnątrzszpitalna wynosiła 12,1%. Wskaźnik śmiertelności wewnątrzszpitalnej był wyższy u mężczyzn 
niż u kobiet; ryzyko zgonu oszacowano na 6,74 (95% CI 6,4–7,0) na 100 osobo-lat leczenia. Największą śmiertelność (13,2%) 
odnotowano w styczniu (w perskim kalendarzu od 11 Dey do 11 Bahman), a najmniejszą (5,9%) — w maju (w perskim 
kalendarzu od 11 Ordibehest do 10 Khordad). Wiek powyżej 84 lat, płeć żeńska, poziom wykształcenia, palenie tytoniu, 
niestosowanie leczenia trombolitycznego, cukrzyca typu 2, ból w klatce piersiowej przed przybyciem do szpitala, blok prawej 
odnogi pęczka Hisa, częstoskurcz komorowy, przezskórna interwencja wieńcowa, MI ściany bocznej i MI z uniesieniem od-
cinka ST (STEMI) były czynnikami determinującymi śmiertelność wewnątrzszpitalną. Częstość względna zgonów była wyższa 
w grupie STEMI niż w non-STEMI (odpowiednio 83,7% vs. 16,3% zgonów w rejestrze z tych dwóch grup).
Wnioski: STEMI, niestosowanie leczenia trombolitycznego, wiek powyżej 84 lat i częstoskurcz komorowy najsilniej wpływały 
na śmiertelność wewnątrzszpitalną wśród chorych z MI. Wyniki niniejszego badania są pomocne w planowaniu monitorowania 
pacjentów i zapewnieniu im właściwej opieki zdrowotnej.
Słowa kluczowe: zawał serca, choroba niedokrwienna serca, śmiertelność wewnątrzszpitalna, czynnik ryzyka
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